Arizona City

1–15 of 15 companies

• 

  AireBeam Communications

  Telecom

  Early stage · 11–50 employees

• 

  BluePipes

  Jobs & recruitment

  Early stage · 2–10 employees

• 

  Cheapdigitaldownload

  Gaming

  Early stage

• 

  Cognify

  Health

  Early stage · 1 employees

• C

  Court Reporter Connect

  Early stage · 2–10 employees

• 

  Crpt

  Early stage · 2–10 employees

• 

  Feeloh

  Feeloh is a platform designed to simplify the planning and enjoyment of local activities with friends. The company operates in the social networking and event planning market, targeting individuals who want to reconnect with loved ones and nurture meaningful friendships without the stress of planning. Feeloh serves a diverse range of clients, from busy professionals to families, who seek to maximize their social life with minimal effort.The business model revolves around providing a hassle-free platform that allows users to discover and lock in plans with friends and family instantly. Users can invite friends to scheduled activities and sync these invites to their calendars, taking the guesswork out of deciding what to do. The platform offers a curated list of activities based on specific interests, making it easier for users to find and enjoy meaningful experiences.Feeloh makes money through a freemium model, offering basic services for free while charging for premium features such as advanced activity suggestions, exclusive event access, and enhanced calendar functionalities. This approach allows the company to attract a broad user base while generating revenue from those who seek additional value.

  Early stage

• 

  Fitness 4 Home Superstore

  Sports

  Early stage · 2–10 employees

• 

  JE Hamilton & Associates

  Legal

  Early stage · 2–10 employees

• 

  Kozee Labs

  Kozee Labs, Inc. operates as a technology firm targeting the home services industry, a market valued at over $400 billion. The concept originated from the founders' negative experiences with home service contractors, which highlighted significant gaps in transparency and reliability within the sector. The company's core offering is an all-in-one mobile application available on both iOS and Android platforms. This platform allows homeowners to manage their property through several features. A key component is the proprietary "Kozee Rating," which utilizes machine learning and artificial intelligence to analyze a home's condition and recommend necessary services. The app serves as a digital repository for storing and transferring home service records, a feature designed to simplify property maintenance history for current and future owners. Furthermore, the platform facilitates on-demand service requests, connecting users with a network of vetted and certified contractors. The founding team combines diverse expertise. Kozee Labs secured $150,00 in a Seed funding round on May 10, 2018, with the J. Orin Edson Entrepreneurship + Innovation Institute as the institutional investor.

  Early stage · 2–10 employees

• 

  Neuresta Inc

  Health

  The company is focused on developing new therapies for chronic pain, a condition that affects one in five adults globally. Neuresta's core strategy involves creating injectable medications that provide localized, prolonged pain relief without the systemic side effects associated with orally administered drugs, which can lead to addiction. The company's technology platform is centered on the genetic re-engineering of Botulinum Neurotoxins (BoNT), which are powerful nerve blockers. Unlike traditional Botox, which can cause muscle paralysis, Neuresta's proprietary method reassembles BoNT from separately produced, inactive protein fragments. This allows for the modification of BoNT to specifically target pain-sensing neurons (nociceptors) without affecting muscle function, offering a significant advantage over existing treatments. This innovative technique emerged from research funded by the UK's Medical Research Council (MRC), with the technology subsequently transferred to Neuresta for development. In early 2021, Neuresta initiated a preclinical development study in collaboration with the U.S. National Center for Advancing Translational Sciences (NCATS), a part of the National Institutes of Health (NIH). This partnership operates under the NIH HEAL Initiative (Helping to End Addiction Long-term), which aims to address the opioid crisis. The company's business model appears to be focused on research and development, seeking partnerships to accelerate its programs and expand the application of its modified BoNT technology to a wider range of chronic pain conditions.

  Early stage

• 

  NMode Solutions

  Semiconductors

  Early stage · 2–10 employees

• 

  Pilot Pro

  Travel, Transportation

  Early stage

• 

  RaeSedo

  Health

  RaeSedo, Inc. is a biotechnology company focused on developing innovative therapeutics for asthma, a prevalent and potentially deadly respiratory disease affecting 10% of the global population. The company leverages cutting-edge research in genomics, human cells, and animal models to identify gaps in current asthma treatments and develop novel solutions. RaeSedo's core product is a replacement therapy using a 10-20 amino acid sequence derived from surfactant protein A (SP-A), which has demonstrated significant anti-inflammatory effects in preclinical studies. This therapy aims to reduce inflammation, mucus production, and airway constriction associated with asthma. The company primarily serves patients suffering from various types of asthma, offering a targeted approach to managing and alleviating symptoms. RaeSedo operates in the pharmaceutical and biotechnology market, utilizing a business model that includes research and development, clinical trials, and eventual commercialization of its therapeutic products. Revenue is generated through the sale of these innovative treatments, as well as potential partnerships and licensing agreements with larger pharmaceutical companies.

  Early stage · $260K raised

• 

  Weller Spring Floor

  Sports

  Early stage